Hyperbaric oxygen improves engraftment of ex-vivo... (2014 study) Skip to main content
Clinical Study Blood cells, molecules & diseases 2014

Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34⁺ cells in a murine model of umbilical cord blood transplantation.

Aljitawi OS, Xiao Y, Eskew JD, Parelkar NK, Swink M, Radel J, et al., Blood cells, molecules & diseases, 2014

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers gave immune-deficient mice a 2-hour session of hyperbaric oxygen before infusing human umbilical cord blood stem cells, then compared them with mice that did not get the oxygen.

What They Found

In a mouse study of umbilical cord blood transplantation, mice given hyperbaric oxygen (100% oxygen at 2.5 atmospheres absolute for 2 hours) showed significantly better retention and engraftment of human CD34-positive cord blood cells than mice kept under normal oxygen conditions. Improved retention was seen in the bone marrow, peripheral blood and spleen. Engraftment of human myeloid and B-cell subsets was also significantly higher in the peripheral blood, spleen and bone marrow. Imaging showed significantly higher bioluminescence values in the treated mice, both on the belly side and the back side. Mice were followed for up to 4.5 months after transplant.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study used immune-deficient mice that were irradiated before transplant, and the abstract reports no human patient data, so the findings may not apply to people.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Wound Care
Source Pubmed
PubMed ID 23953010
Year Published 2014
Journal Blood cells, molecules & diseases
MeSH Terms Animals; Antigens, CD34; B-Lymphocyte Subsets; Bone Marrow Cells; Cord Blood Stem Cell Transplantation; Female; Gene Expression; Genes, Reporter; Graft Rejection; Graft Survival; Humans; Hyperbaric Oxygenation; Injections, Intravenous; Luciferases; Mice

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology